The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial
Stephen M. Stick*, Alexia Foti, COMBAT CF Study Group, Robert S. Ware, Harm A.W.M. Tiddens, Barry S. Clements, David S. Armstrong, Hiran Selvadurai, Andrew Tai, Peter J. Cooper, Catherine A. Byrnes, Yvonne Belessis, Claire Wainwright, Adam Jaffe, Philip Robinson, Lisa Saiman, Peter D. Sly
Research output: Contribution to journal › Article › Academic › peer-review
30Citations
(Scopus)
58Downloads
(Pure)
Fingerprint
Dive into the research topics of 'The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial'. Together they form a unique fingerprint.